NCT02657473View on ClinicalTrials.gov

Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

August 13, 2016

Primary Completion Date

December 13, 2019

Study Completion Date

December 13, 2019

Conditions
Non-CF Bronchiectasis
Interventions
DRUG

tobramycin inhalation solution

DRUG

Saline 0.9% inhalation solution

Trial Locations (6)

1815JD

North West Clinics, Alkmaar

Unknown

VU Medical Center, Amsterdam

Zuyderland Medisch Centrum, Heerlen

Spaarne Gasthuis, Hoofddorp

Canisius Ziekenhuis, Nijmegen

UMCU, Utrecht

Sponsors
All Listed Sponsors
lead

Medical Center Alkmaar

OTHER